Cover of Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger (EDT), Steve Olson (EDT): Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger (EDT), Steve Olson (EDT) Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research

Workshop Summary

Price for Eshop: 921 Kč (€ 36.8)

VAT 0% included

New

E-book delivered electronically online

E-Book information

National Academies Press

2010

EPub
How do I buy e-book?

84

978-0-309-17713-9

0-309-17713-8

Annotation

Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.

Ask question

You can ask us about this book and we'll send an answer to your e-mail.